Pfizer Pilot Aims Local To Help China Kick Smoking Habit
This article was originally published in PharmAsia News
Executive Summary
Innovative drug makers are resorting to patient assistance and commercial insurance programs for their high-priced therapies in China. Pfizer is test-driving a new approach for its smoking cessation drug.